Senate Expected To Vote On US FDA User-Fee Bill August 3

Senate Majority Leader Mitch McConnell, R-Kent., filed cloture on H.R. 2430, the FDA Reauthorization Act on device and drug user fees this week, and indicated debate and a vote on the bill will likely take place on Aug. 3.

More from Legislation

More from Policy & Regulation